Cleerly to Present New Clinical Evidence on AI-Enabled CCTA at ACC.23/WCC
Cleerly to Present New Clinical Evidence on AI-Enabled CCTA at ACC.23/WCC Research shows accuracy and effectiveness of Cleerly’s personalized...
Cleerly to Present New Clinical Evidence on AI-Enabled CCTA at ACC.23/WCC Research shows accuracy and effectiveness of Cleerly’s personalized...
Cleerly Hires Udo Hoffmann, MD MPH as Chief Scientific Officer Cardiovascular clinical trial expert brings AI imaging experience to lead research...
New alliance combines Cleerly’s AI-enabled approach to identifying early signs of heart disease with Heartbeat Health’s nationwide footprint of...
Cleerly introduces Proxy solution to improve heart disease imaging workflows Proxy allows for seamless data transmission and improved AI-based plaque...
Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.
<div style="padding:56.25% 0 0 0; position:relative;"><iframe src="https://player.vimeo.com/video/708877726?h=61fd91e16c&badge=0&autopause=0&player_id=0&app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture" allowfullscreen style="position:absolute; top:0;left:0; width:100%; height:100%;" title="Cleerly / Beats"></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>